Video

Preventing Opioid Addiction in Patients With Cancer

Jaron Mark, M.D., a gynecologic oncology fellow at Roswell Park Comprehensive Cancer Center, discusses the opioid crisis, and the steps that his institution is taking to combat potential addiction in women who undergo surgery for gynecologic cancer.

Jaron Mark, M.D., a gynecologic oncology fellow at Roswell Park Comprehensive Cancer Center, discusses the opioid crisis, and the steps that his institution is taking to combat potential addiction in women who undergo surgery for gynecologic cancer.

According to Mark, the crisis started in more than three decades ago when research was published in the New England Journal of Medicine stating that opioid addiction is low in hospitalized patients. People misinterpreted these findings to mean that opioids were not addictive, and by the 1990s, these drugs were being heavily marketed and prescribed.

At Roswell Park, Mark and his team found that many women who had surgery for their cancer reported not using the opioids that were prescribed to them. So, they stopped prescribing opioid pills for patients undergoing minimally invasive surgery or minor outpatient procedures.

Related Videos
Image of Doctor with blonde hair.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Related Content